Univest
Univest
  • Markets

Amanta Healthcare Share Price Target 2026 Analyst Forecast Bull and Bear Case

  • June 5, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Amanta Healthcare Share Price Target

The Amanta Healthcare share price target 2026 is Rs 150, implying approximately 20 percent upside from the current market price of Rs 125 (NSE: AMANTA). Q4 FY26 results announced May 30, 2026 are the key near-term re-rating trigger, with Specialty Pharmaceutical Products tailwinds and RBI rate cuts supporting the path to Rs 150.

The Amanta Healthcare share price target 2026 is Rs 150, based on analyst estimates and the FY27 earnings recovery thesis. Q4 FY26 results announced May 30, 2026 are the immediate trigger for re-rating Amanta Healthcare (NSE: AMANTA). This article covers the complete Amanta Healthcare share price target analysis including sector tailwinds, key risks, and the bull and bear case scenarios.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Amanta Healthcare Company Overview
  • Why Is the Amanta Healthcare Share Price Target Set at Rs 150 for 2026
    • FY27 Earnings Delivery and Revenue Acceleration
    • Structural Sector Tailwinds in Specialty Pharmaceutical Products
    • RBI Rate Cut Cycle and Lower Cost of Capital
    • Union Budget 2026-27 Policy Support
    • Improving FII Flows Post the April 2026 Tariff Shock
  • Amanta Healthcare Share Price Targets: Short Term, 12 Month, and Long Term
    • Short Term Amanta Healthcare Share Price Target: 3 to 6 Months
    • 12-Month Amanta Healthcare Share Price Target 2026
    • Long Term Amanta Healthcare Share Price Target: FY27 to FY28
  • Bull Case and Bear Case for the Amanta Healthcare Share Price Target
    • Bull Case Amanta Healthcare Share Price Target: Rs 180
    • Bear Case Amanta Healthcare Share Price Target: Rs 100
  • Key Risks to the Amanta Healthcare Share Price Target 2026
    • US Tariff and Global Macro Risk
    • Valuation and Earnings Miss Risk
    • Competitive Pressure in Specialty Pharmaceutical Products
    • FII Selling Pressure and Liquidity Risk
  • How to Invest in Amanta Healthcare
  • FAQs on Amanta Healthcare Share Price Target 2026
    • What is the Amanta Healthcare share price target for 2026?
    • Is Amanta Healthcare a good buy at the current price of Rs 125?
    • What is the 52 week high and low of Amanta Healthcare?
    • What are the key risks to the Amanta Healthcare share price target 2026?
    • What are the main catalysts for the Amanta Healthcare share price target?
    • What is the Amanta Healthcare share price target for 2027?

Amanta Healthcare Company Overview

Amanta Healthcare (NSE: AMANTA) is a Bengaluru-based specialty pharma company producing contrast media, injectable formulations, and specialty drugs for hospital and institutional clients. At CMP Rs 125 against a 52 week range of Rs 89 to Rs 225, the stock trades at a meaningful discount to its 52 week high. Market capitalisation stands at Rs 188 crore with a trailing PE of sector-average.

Parameter Value
NSE Ticker AMANTA
Sector Specialty Pharmaceutical Products
CMP (May 30, 2026) Rs 125
52 Week High Rs 225
52 Week Low Rs 89
Market Cap Rs 188 crore
Trailing PE sector-average
12-Month Analyst Target Rs 150
Bull Case Target Rs 180
Bear Case Target Rs 100

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Our research team has now shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks now on Univest

See the Stocks →

Why Is the Amanta Healthcare Share Price Target Set at Rs 150 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Amanta Healthcare share price target 2026 of Rs 150 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the recovery trajectory are the most direct catalyst for re-rating from CMP Rs 125 toward the Amanta Healthcare share price target of Rs 150.

Structural Sector Tailwinds in Specialty Pharmaceutical Products

The Specialty Pharmaceutical Products sector is expanding on the back of India’s strong domestic demand, PLI scheme support, and rising corporate investment. Amanta Healthcare’s market position creates a structural growth runway supporting the Amanta Healthcare share price target consensus of Rs 150 and the bull case of Rs 180.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle, which began in early 2026, reduces Amanta Healthcare’s borrowing costs and stimulates demand across end markets. Lower interest costs improve EPS trajectory, directly supporting the Amanta Healthcare share price target 2026 of Rs 150.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Amanta Healthcare’s Specialty Pharmaceutical Products operations, improving the probability of achieving the Amanta Healthcare share price target of Rs 150.

Improving FII Flows Post the April 2026 Tariff Shock

As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering through FY27. At sector-average PE, Amanta Healthcare is positioned as a beneficiary of institutional reallocation supporting the path to Rs 150.

Amanta Healthcare Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Amanta Healthcare Share Price Target: 3 to 6 Months

The near-term Amanta Healthcare share price target is anchored to support near the 52 week low of Rs 89. A confirmed Q4 FY26 earnings recovery and positive FY27 guidance are the triggers for an initial 10 to 15 percent re-rating toward Rs 150.

12-Month Amanta Healthcare Share Price Target 2026

The 12-month Amanta Healthcare share price target 2026 is Rs 150, implying approximately 20 percent upside from CMP Rs 125. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker AMANTA.

Long Term Amanta Healthcare Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Amanta Healthcare share price target is Rs 180 in the bull case, assuming full earnings delivery through FY27 to FY28 and sector re-rating in the Specialty Pharmaceutical Products space.

Bull Case and Bear Case for the Amanta Healthcare Share Price Target

Bull Case Amanta Healthcare Share Price Target: Rs 180

The bull case for the Amanta Healthcare share price target of Rs 180 materialises when FY27 earnings beat analyst estimates, sector tailwinds accelerate, and FII flows return strongly to Indian equities. The stock re-rates toward higher peer multiples, making Rs 180 achievable within FY28.

Bear Case Amanta Healthcare Share Price Target: Rs 100

The bear case sees the Amanta Healthcare share price target testing Rs 100 if FY27 earnings disappoint and FII outflows persist. At Rs 100, the stock approaches the 52 week low support of Rs 89, requiring a full reassessment of the investment thesis.

Scenario Target Key Conditions
Bull Case Rs 180 FY27 earnings beat, sector re-rating, strong FII inflows
Base Case Rs 150 In-line FY27 delivery, partial FII recovery
Bear Case Rs 100 FY27 earnings miss, guidance cut, sustained FII outflows

Key Risks to the Amanta Healthcare Share Price Target 2026

US Tariff and Global Macro Risk

The 26 percent US reciprocal tariff announced April 2, 2026 triggered FII outflows across Indian equities. Prolonged trade tension or a global demand slowdown remains the most prominent macro risk to the Amanta Healthcare share price target 2026 of Rs 150.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could trigger multiple compression, posing a direct risk to the Amanta Healthcare share price target of Rs 150. Monitoring quarterly results closely is essential for investors in Amanta Healthcare.

Competitive Pressure in Specialty Pharmaceutical Products

Intensifying competition in the Specialty Pharmaceutical Products sector could compress Amanta Healthcare’s pricing power and market share over the medium term, which must be factored into any assessment of the Amanta Healthcare share price target of Rs 150.

FII Selling Pressure and Liquidity Risk

Sustained FII outflows from Indian equities can delay re-rating toward the Amanta Healthcare share price target of Rs 150 regardless of company-level operational improvement through FY27.

How to Invest in Amanta Healthcare

Check the Univest Screener for live data

Begin by reviewing Amanta Healthcare’s Q4 FY26 results, annual report, and FY27 guidance statements before forming a view on the Amanta Healthcare share price target of Rs 150. Focus on revenue growth trajectory, margin trends, and management commentary on sector headwinds and opportunities.

Open a Demat and trading account with a SEBI registered stockbroker to buy Amanta Healthcare (NSE: AMANTA) with full regulatory protection. Ensure KYC is complete and understand the Specialty Pharmaceutical Products sector dynamics before executing any position.

Plan your entry near the 52 week low support of Rs 89. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance would strengthen the entry case for the Amanta Healthcare share price target of Rs 150. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in smaller-cap Specialty Pharmaceutical Products companies where liquidity and volatility can amplify losses.

Always consult a SEBI registered financial advisor before investing based on any Amanta Healthcare share price target estimate. A registered advisor personalises recommendations based on your risk profile and financial goals. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Amanta Healthcare’s live price and get daily stock recommendations.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.

FAQs on Amanta Healthcare Share Price Target 2026

What is the Amanta Healthcare share price target for 2026?

Ans. The Amanta Healthcare share price target 2026 is Rs 150, implying approximately 20 percent upside from CMP Rs 125. The bull case target is Rs 180 and the bear case target is Rs 100.

Is Amanta Healthcare a good buy at the current price of Rs 125?

Ans. At Rs 125, Amanta Healthcare offers potential upside to the share price target of Rs 150 if FY27 earnings recover as projected. Consult a SEBI registered financial advisor before making any investment decision.

What is the 52 week high and low of Amanta Healthcare?

Ans. The 52 week high of Amanta Healthcare is Rs 225 and the 52 week low is Rs 89. At CMP Rs 125, the stock offers upside potential toward the 12-month share price target of Rs 150.

What are the key risks to the Amanta Healthcare share price target 2026?

Ans. Key risks to the Amanta Healthcare share price target of Rs 150 include an FY27 earnings miss, US tariff-driven FII outflows, competitive pressure in Specialty Pharmaceutical Products, and broader market volatility.

What are the main catalysts for the Amanta Healthcare share price target?

Ans. Primary catalysts include FY27 PAT recovery, structural tailwinds in Specialty Pharmaceutical Products, RBI rate cut support, Union Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities through FY27.

What is the Amanta Healthcare share price target for 2027?

Ans. The long-term Amanta Healthcare share price target for FY27 to FY28 is Rs 180 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.



News Share Price Target
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply